Ortho Clinical Diagnostics Sponsors AACC Webinar Nov. 19: 'Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury'

Ortho Clinical Diagnostics Sponsors AACC Webinar Nov. 19: 'Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury'

Nov 11, 2014

November 11, 2014 -- This September, the FDA cleared a new biomarker for Acute Kidney Injury (AKI) that gives clinicians one more tool to help identify patients at risk of developing AKI, a condition recognized as a major risk factor for chronic kidney disease progression.

On November 19, John A. Kellum, MD, of the University of Pittsburgh will sit down with AACC for an exclusive webinar where he will discuss how clinicians can utilize this newly-approved biomarker to identify AKI risk earlier, and potentially prevent adverse outcomes by initiating therapeutic interventions.

Learn how newly-cleared biomarkers are changing the way labs are addressing AKI.

${loading}